Zusammenfassung
Es wird versucht, einen Überblick über die pathophysiologischen Regulationsmechanismen des Renin-Angiotensin-Aldosteron-Systems (RAAS) zu geben.
Zunächst wird die Anatomie des iuxtaglomerulären Apparates besprochen. Dann wird auf diejenigen Substanzen eingegangen, die zur Synthese und zum Abbau von Angiotensin II von Bedeutung sind, nämlich Renin, Angiotensinogen, Angiotensin I, converting enzyme und die Angiotensinasen. Die Methodik der Renin- bzw. Angiotensinbestimmung wird kurz angeführt.
Die Wirkungen des Hormons Angiotensin II auf das Herz-Kreislaufsystem, die Niere, die Nebenniere, das vegetative Nervensystem und den Katecholaminstoffwechsel werden beschrieben.
Schließlich werden die Untersuchungen erläutert, die bezüglich der Regulation der Reninsekretion durchgeführt wurden, so vor allem die Baroreceptor- und Macula densa-Theorie sowie eine neue „Zwei-Wege-Hahn-Theorie“, welche die wesentlichsten Befunde in einleuchtender Weise zu erklären versucht.
Anhand der Diuretikawirkung auf das RAAS wird jedoch hervorgehoben, daß anscheinend noch weitere regulative Vorgänge, insbesondere humorale Stimuli, an der Reninfreisetzung beteiligt sein müssen.
Summary
The attempt has been made to give an over-all view of the pathophysiological regulatory mechanisms of the renin angiotensin aldosterone system (RAAS).
First, the anatomy of the iuxtaglomerular apparatus is discussed. Then those substances are considered which are important to the synthesis and decomposition of angiotensin II, namely renin, angiotensinogen, angiotensin I, converting enzyme and the angiotensinases. The renin- respectively angiotensin determination method is briefly cited.
The effects of the hormone angiotensin II on the heart and circulatory system, the kidneys, the adrenal glands, the vegetative nervous system and catecholamine metabolism are described.
Finally, those experiments are cited which have been carried out concerning the regulation of renin secretion, especially the baroreceptor- and macula densa theory. A new „two way tap theory“ which attempts to explain the important findings in an enlightening way is also noted.
However, considering the effect of diuretics on the RAAS, it is emphasized that still further regulatory mechanisms, especially humoral stimuli, must be participant in renin release.
Literatur
Ames, R. P., A. J. Borkowski, A. M. Sicinski, and J. H. Laragh: Prolonged infusions of angiotensin II and norepinephrine on blood pressure, electrolyte balance, aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J. clin. Invest.44 1171 (1965).
Arakawa, K., M. Nakatani, and M. Nakamura: Purification of human angiotensin. Nature (Lond.)214 278 (1967).
Avenhaus, H., W. Gerlach u. E. Buchborn: Wirkungsvergleich pressorischer Substanzen bei Gesunden. Klin. Wschr.44 314 (1966).
Barajas, L., and H. Latta: A three-dimensional study of the iuxtaglomerular apparatus in the rat; light and electron microscopic observations. Lab. Invest.12 257 (1963).
—— —— The iuxtaglomerular apparatus in adrenalectomized rats. Lab. Invest.12 1046 (1963).
-- -- Structure of the iuxtaglomerular apparatus. Circulat. Res., Suppl. II-15 (1967).
Benetato, G., J. Haulica, M. Uliutu, E. Bubiaun, J. Mocodeau, P. Stefanescu, and G. Suhaciu: The central nervous action of angiotensin on aldosterone secretion and electrolytic balance. Int. J. Neuropharmacol.3 565 (1964).
Bickerton, R. K., and J. P. Buckley: Evidence for a central mechanism in angiotensin-induced hypertension. Proc. Soc. exp. Biol. (N. Y.)106 834 (1961).
Bing, J.: Mechanism of the increased sensitivity to renin in nephrectomized animals. Acta path. microbiol. scand.60 311 (1964).
Biron, P., M. Chretien, E. Koiw, and J. Genest: Effects of angiotensin infusions on aldosterone and electrolyte excretions in normal subjects and patients with hypertension and adrenocortical disorders. Brit. med. J.1962 I 1569.
Blaquier, P.: Kinetic studies on renin-angiotensinogen reaction after nephrectomy. Amer. J. Physiol.208 1083 (1965).
Bock, K. D., u. H. J. Krecke: Die Wirkung von synthetischem Hypertensin II auf die PAH- und Inulin-Clearance, die renale Haemodynamik und die Diurese beim Menschen. Klin. Wschr.36 69 (1958).
—— —— u. H. M. Kuhn: Untersuchungen über die Wirkung von synthetischem Hypertensin II auf Blutdruck, Atmung und Extremitätendurchblutung des Menschen. Klin. Wschr.36 254 (1958).
——, u. F. Gross: Venendruckänderungen nach Gabe von Renin, Angiotensin und Noradrenalin. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.242 188 (1961).
——, and M. Meier: The effect of atropine on cardiovascular reactions elicited by catecholamines, angiotensin, histamine, serotonin and acetylcholine in the conscious dog. Arch. int. Pharmacodyn.142 444 (1963).
Boucher, R., P. Biron, and J. Genest: Procedure for isolation and determination of human blood angiotensin. Canad. J. Biochem.39 581 (1961).
—— R. Veyrat, J. de Champlain, and J. Genest: New procedures for measurement of human plasma angiotensin and renin activity levels. Canad. med. Ass. J.90 194 (1964).
Boyd, G. W., J. Landon, and W. S. Peart: Radioimmunoassay for determining plasma levels of angiotensin II in man. Lancet1967 II 1002.
——, and W. S. Peart: The production of high-titre antibody against free angiotensin II. Lancet1968 II 129.
Braun-Menendez, E., J. C. Fasciolo, L. F. Leloir, and J. M. Munoz: The substance causing renal hypertension. J. Physiol. (Lond.)98 283 (1940).
Britton, K. E.: Renin and renal autoregulation. Lancet1968 II 329.
Brodehl, J., u. K. Gellissen: Der Einfluß des Angiotensins II auf die tubuläre Phosphatrückresorption beim Menschen. Klin. Wschr.44 1171 (1966).
Brown, J. J., D. L. Davies, P. B. Doak, A. F. Lever, and J. I. S. Robertson: Serial estimation of plasma renin concentration during pregnancy and after parturition. J. Endocr.35 373 (1966).
—— —— A. F. Lever, and J. I. S. Robertson: Plasma renin concentration in human hypertension. I.: Relationship between renin, sodium and potassium. Brit. med. J.1965 II 144.
—— —— —— ——, and M. Tree: The estimation of renin in human plasma. Biochem. J.93 594 (1964).
——, and W. S. Peart: The effect of angiotensin on urine flow and electrolyte excretion in hypertensive patients. Clin. Sci.22 1 (1962).
Brown, T. C., J. O. Davis, and C. I. Johnston: Acute response in plasma renin and aldosterone secretion to diuretics. Amer. J. Physiol.211 437 (1966).
Brubacher, E. S., and A. J. Vander: Sodium deprivation and renin secretion in unaesthetized dogs. Amer. J. Physiol.214 15 (1968).
Buckley, J. P.: Effect of synthetic angiotensin II on catecholamine levels and biological activity. Acta physiol. scand.65 273 (1965).
Bumpus, F. M., H. Schwarz, and I. H. Page: Synthesis and pharmacology of the octapeptide angiotonin. Science125 3253 (1957).
Burg, M. B., and J. Orloff: Control of fluid absorption in the renal proximal tubule. J. clin. Invest.47 2016 (1968).
Carretero, O., and F. Gross: Evidence for humoral factors participating in the renin substrate reaction. Circulat. Res.21, Suppl. II–115 (1967).
Catt, K. J., M. C. Cain, and J. P. Coghlan: Measurement of angiotensin II in blood. Lancet1967 II 1005.
Cession, G., et A. Cession-Fossiou: Stimulation par l'angiotensine du système adrenergique. Ann. Endocr. (Paris)27 3 (1966).
Conway, J., and H. Palmero: Vascular effect of the thiazide diuretics. Arch. intern. Med.111 203 (1963).
Cook, W. F., and G. W. Pickering: The location of renin in the kidney. Biochem. Pharmacol.10 165 (1962).
Crane, R. K., G. Forstner, and A. Eichholz: An effect of Na+-concentration on the apparent Michaelis constants for intestinal sugar transport in vitro. Biochim. biophys. Acta (Amst.)109 467 (1965).
Davis, J. O.: The regulation of aldosterone secretion. In: The adrenal cortex, ed. by Albert B. Eisenstein, p. 203. Boston 1967.
-- S. S. Howards, C. I. Johnston, and F. S. Wright: Renin, sodium-retaining and sodium-excreting hormones and experimental renal hypertension. Circulat. Res., Suppl. II–167 (1967).
Davis, W. W., L. R. Burwell, G. Kelley, A. G. T. Casper, and F. C. Bartter: Studies of the loci of stimulation of aldosterone biosynthesis during sodium depletion. Biochem. biophys. Res. Commun.22 218 (1966).
Bono, E. de, G. J. Lee, F. R. Mottram, G. W. Pickering, J. J. Brown, H. Keen, W. S. Peart, and P. H. Sanderson: The action of angiotensin in man. Clin. Sci.25 123 (1963).
Champlain, J. de, J. Genest, R. Veyrat, and R. Boucher: Factors controlling renin in man. Trans. Ass. Amer. Phyens.78 135 (1965).
—— —— —— —— Factors controlling renin release in man. Arch. intern. Med.117, 335 (1966).
Dengler, H.: Über einen reninähnlichen Wirkstoff in Arterienextrakten. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.227 481 (1956).
Deodhar, S. D., E. Haas, and H. Goldblatt: Production of antirenin to homologous renin and its effect on experimental renal hypertension. J. exp. Med.119 425 (1964).
Doyle, A. E., W. J. Louis, G. Jerums, and E. C. Osborn: Metabolism and blood levels following infusion of a radioactive analog of angiotensin. Amer. J. Physiol.215 164 (1968).
Dustan, H. P., G. R. Cumming, A. C. Corcoran, and I. H. Page: A mechanism of chlorothiazide-enhanced effectiveness of antihypertensive ganglioplegic drugs. Circulation19 360 (1959).
Eigler, F. W.: Regulierung von Glomerulumfiltrat und arteriellem Blutdruck durch den Natriumgradienten an den Macula-densa-Zellen. Eine Hypothese über die Stimulierung des Renin-Angiotensin-Systems. Klin. Wschr.45 23 (1967).
Elliott, D. P., and W. S. Peart: The amino acid sequence in a hypertensin. Biochem. J.65 246 (1957).
Endres, P., W. Siegenthaler, K. Baumann, E. Gysling, H. Rubli, M. Schönbeck, P. Weidmann, u. C. Werning: Die Plasma-Renin-Aktivität im peripheren venösen Blut unter verschiedenen Stimulationsbedingungen. Dtsch. med. Wschr.94, 1049 (1969).
Fasciolo, J. C., E. de Vito, J. C. Romero, and J. N. Cucchi: The renin content of the blood of humans and dogs under several conditions. Canad. med. Ass. J.90 206 (1964).
Finkielman, S., M. Worcel, Z. M. Massani, V. E. Nahmod, A. C. Paladini, and A. Agrest: Angiotensin blood levels in hypovolemic shock during osmotic diuresis. Amer. J. Physiol.215 308 (1968).
Fowler, N. O., and J. C. Holmes: Coronary and myocardial actions of angiotensin. Circulat. Res.14 191 (1964).
Fraser, R., V. H. T. James, J. J. Brown, P. Isaac, A. F. Lever, and J. I. S. Robertson: Effect of angiotensin and of frusemide on plasma aldosterone, corticosterone, cortisol and renin in man. Lancet1965 II 989.
Gauer, O. H.: Osmocontrol versus volume control. Fed. Proc.27 1132 (1968).
——, and J. P. Henry: Circulatory basis of fluid volume control. Physiol. Rev.43 423 (1963).
Genest, J., W. Nowaczynski, E. Koiw, T. Sandor, and P. Biron: Adreno-cortical function in essential hypertension. In: Essential hypertension. An Internat. Symposium ed. by K. D. Bock and P. T. Cottier. Berlin-Göttingen-Heidelberg: Springer 1960.
Goldblatt, H.: Studies on experimental hypertension due to renal ischemia. Ann. intern. Med.69 11 (1937).
—— Y. J. Katz, H. A. Lewis, and E. Richardson: Studies on experimental hypertension. XX. The bioassay of renin. J. exp. Med.77 309 (1943).
Goldstein, M., M. Levitt, A. Hauser, and D. Polimeros: Effect of metalluride on solute and water excretion in hydrated man; comments on side of action. J. clin. Invest.40 731 (1961).
Goormaghtigh, N.: Existence of an endocrine gland in the media of the renal arterioles. Proc. Soc. exp. Biol. (N. Y.)42 688 (1939).
Gordon, R. D., O. Küchel, G. W. Liddle, and D. P. Island: Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J. clin. Invest.46 599 (1967).
—— L. K. Wolfe, D. P. Island, and G. W. Liddle: A diurnal rhythm in plasma renin activity in man. J. clin. Invest.45 1587 (1966).
Gross, F.: Renin und Hypertensin, physiologische oder pathologische Wirkstoffe. Klin. Wschr.36 46 (1958).
—— Aktivität des RAS und Sekretion von Aldosteron während der Schwangerschaft. Geburtsh. Frauenheilk.26 141 (1966).
—— H. Brunner, and M. Ziegler: Renin-angiotensin-system, aldosterone and sodium balance. Recent Progr. Hormone Res.21 119 (1965).
Gunnels, J. C., C. E. Grim, R. R. Robinson, and N. M. Wildermann: Plasma renin activity in healthy subjects and patients with hypertension. Arch. intern. Med.119 232 (1967).
Haas, E., H. Goldblatt, and E. C. Gipson: Extraction, purification and acetylation of human renin and the production of antirenin to human renin. Arch. Biochem.110 534 (1965).
Hartroft, P. M., L. N. Newmark, and J. A. Pitcock: Relationship of renal iuxtaglomerular cells to sodium intake, adrenal cortex and hypertension. In: Hypertension, ed. by J. Moyer. Philadelphia: W. B. Saunders Co. 1959.
Haynes, F. W., P. H. Forsham, and D. M. Hume: Effects of ACTH, cortisone, desoxycorticosterone and epinephrine on the plasma hypertensinogen and renin concentration of dogs. Amer. J. Physiol.172 265 (1953).
Heidenreich, O., Y. Kook, L. Baumeister u. E. Reus: Stoffwechselwirkungen von synthetischem Angiotensin II. Arch. intern. Pharmacodyn.148 309 (1964).
Helmer, O. M.: Differentiation between two forms of angiotonin by means of spirally cut strips of rabbit aorta. Amer. J. Physiol.188 571 (1957).
——, and R. S. Griffith: Biological activity of steroids as determined by assay of renin-substrate (hypertensinogen). Endocrinology49 154 (1951).
——, and W. E. Judson: The quantitative determination of renin in the plasma of patients with arterial hypertension. Circulation27 1050 (1963).
Hess,, R., and F. Gross: Glucose-6-phosphate-dehydrogenase and renin in kidneys of hypertensive or adrenalectomized rats. Amer. J. Physiol.197 869 (1959).
Hodge, R. L., K. K. F. Ng, and J. R. Vane: Disappearance of angiotensin from the circulation of the dog. Nature (Lond.)215 135 (1967).
Ikeda, M., J. Fujii, K. Murata, F. Terasawa, T. Ozawa, S. Hosoda, H. Kurihara, S. Kimata, and S. Okinaka: Effect of angiotensin on cerebral circulation in unaesthetized rabbits. Jap. Circulat. J.27 277 (1963).
Johnson, W. P., and R. A. Bruce: Hemodynamic and metabolic effects of angiotensin II during rest and exercise in normal healthy subjects. Amer. Heart J.63 212 (1962).
Kaneko, Y., J. W. McCubbin, and I. H. Page: Ability of vasoconstrictor drugs to cause adrenal medullary discharge after „sensitization“ by ganglion stimulating agents. Circulat. Res.9 1247 (1961).
Kemp, E., and I. Rubin: Molecular weight of renin determined by sephadex gel-filtration. Acta chem. scand.18 2403 (1964).
Khairallah, P. A., I. H. Page, F. M. Bumpus, and R. R. Smeby: Angiotensin II. Its metabolic fate. Science138 523 (1962).
Klaus, D.: Regulation der Reninsekretion. Dtsch. med. Wschr.92 2128 (1967).
——, and P. Biron: Electrophoretic behaviour of serum angiotensinase. Nature (Lond.)204 381 (1964).
——, u. A. Bocskor: Regulation der Reninsekretion beim Natriummangel. Med. Welt42 2259 (1968).
——, u. A. Heizmann: Methoden für die Bestimmung der Reninaktivität im Plasma. Z. klin. Chem.6 1 (1968).
Kokubu, T., E. Ueda, S. Fujimoto, K. Hiwada, H. Sanga, and Y. Yamamura: Plasma angiotensinase activity in liver disease. Clin. chim. Acta12 484 (1965).
Krück, F.: Hypokaliaemische Hypertension. Internist (Berl.)9 97 (1968).
Kuhn, W.: Haarnadelgegenstromprinzip als Grundlage der Harnkonzentrierung in der Niere. Klin. Wschr.37 997 (1959).
Landwehr, D. M., J. Schnermann, R. M. Klose, and G. Giebisch: Effect of reduction in filtration rate on renal tubular sodium and water reabsorption. Amer. J. Physiol.215 687 (1968).
Laragh, J. H., M. Angers, W. G. Kelly, and S. Lieberman: Hypotensive agents and pressor substances. J. Amer. med. Ass.174 234 (1960).
—— P. J. Cannon, R. P. Ames, A. M. Sicinski, C. J. Bentzel and J. I. Meltzer: Angiotensin II and renal sodium transport, natriuresis and diuresis in patients with cirrhosis and ascites. J. clin. Invest.41 1375 (1962).
Lever, A. F.: The vasa recta and countercurrent multiplication. Acta med. scand., Suppl. 434 (1965).
—— J. I. S. Robertson, and M. Tree: The estimation of renin in plasma by an enzyme kinetic technique. Biochem. J.91 346 (1964).
Lewis, E. J., M. D. Blaufox, and R. B. Hickler: Renin secretion by the denervated kidney. Brit. med. J.1966 II 1430.
Lewis, G. P., and E. Reit: Further studies on the actions of peptides on the superior cervical ganglion and suprarenal medulla. Brit. J. Pharmacol.26 444 (1966).
Leyssac, P. P., U. V. Lassen, and J. H. Thaysen: Inhibition of sodium transport in isolated renal tissue by angiotensin. Biochim. biophys. Acta (Amst.)48 602 (1961).
Liebau, H., A. Distler u. H. P. Wolff: Untersuchungen zur indirekten sympathikomimetischen Wirkung von Angiotensin an isolierten Blutgefäßen. Klin. Wschr.44 322, (1966).
Maier, G. D., and W. S. Morgan: Purification of hog renin by column chromatography. Biochim. biophys. Acta (Amst.)128 193 (1966).
McGiff, J. C.: The natriuretic effect of angiotensin in dogs revealed after administration of reserpine and guanethidine. Circulat. Res.20 664 (1967).
Miller, R. E., A. J. Vander, R. S. Kowalczyk, and G. W. Geelhoed: Aldosterone secretion and plasma renin during renin infusion and acute salt depletion. Amer. J. Physiol.214 228 (1968).
Müller, J.: Aldosterone stimulation in vitro. III. Site of action of different aldosterone-stimulating substances on steroid biosynthesis. Acta endocr. (Kbh.)52 515 (1966).
——, and W. H. Ziegler: Stimulation of aldosterone biosynthesis in vitro by serotonin. Acta endocr. (Kbh.)59 23 (1968).
Nairn, R. C., K. B. Fraser, and C. S. Chadwick: The histological localisation of renin with fluorescent antibody. Brit. J. exp. Path.40 155 (1959).
Nash, F. D., H. H. Rostorfer, M. D. Bailie, R. L. Wathen, and E. G. Schneider: Renin release; Relation to renal sodium load and dissociation from hemodynamic changes. Circulat. Res.22 473 (1968).
Ng, K. K. F., and J. R. Vane: Conversion of angiotensin I to angiotensin II. Nature (Lond.)216 762 (1967).
Nilsson, O.: The adrenergic innervation of the kidney. Lab. Invest.14 1392 (1965).
Page, I. H., and F. M. Bumpus: Angiotensin. Physiol. Rev.41 331 (1960).
Paladini, A. C., E. Braun-Menendez, I. S. del Frade, and Z. M. Massani: The estimation of angiotensin in blood. J. Lab. clin. Med.53 264 (1959).
Peach, M. J., W. H. Cline, and D. T. Watts: Release of adrenal catecholamines by angiotensin II. Circulat. Res.19 571 (1966).
Peart, W. S., and J. J. Brown: Effect of angiotensin (hypertensin or angiotensin) on urine flow and electrolyte excretion in hypertensive patients. Lancet1961 I 28.
Peters, G.: Renal tubular effect of val-5-angiotensin II-amide in rats. Proc. Soc. exp. Biol. (N. Y.)112 771 (1963).
Pickens, P. T., F. M. Bumpus, A. M. Lloyd, R. R. Smeby, and I. H. Page: Measurement of renin activity in human plasma. Circulat. Res.17 438 (1965).
Pickering, G. W., and M. Prinzmetal: The effect of renin on urine formation. J. Physiol. (Lond.)98 314 (1940).
Rector, C., N. Carter, and W. Seldin: The mechanism of bicarbonate reabsorption in the proximal and distal tubulus of the kidney. J. clin. Invest.44 278 (1965).
Rosenthal, J., R. Boucher, W. Nowaczynski, and J. Genest: Acute changes in plasma volume, renin activity and free aldosterone levels in healthy subjects following fursemide administration. Canad. J. Physiol. Pharmacol.46 85 (1968).
Ryan, J. W.: Renin-like enzyme in the adrenal gland. Science158 1589 (1967).
—— J. K. McKenzie, and M. R. Lee: A rapid simple method for the assay of renin in rabbit plasma. Biochem. J.108 679 (1968).
Sakurai, T., and Y. Hashimoto: The vasoconstrictor action of angiotensin in relation to catecholamines. Jap. J. Pharmacol.15 223 (1965).
Schröder, E.: Beziehungen zwischen Plasmarenin, Hochdruck und Natrium im Plasma und in den Erythrozyten. Dtsch. med. Wschr.93 13 (1968).
Schwyzer, R., B. Iselin, H. Kappeler, B. Riniker, W. Rittel u. H. Zuber: Synthese hochwirksamer Dekapeptide mit der Aminosäuresequenz des val-5-hypertensins I. Helv. chim. Acta41 1273 (1958).
Segel, N., T. J. Bayley, A. Paton, P. W. Dykes, and J. M. Bishop: The effects of synthetic vasopressin and angiotensin on the circulation in cirrhosis of the liver. Clin. Sci.25 43 (1963).
Seldin, D., H. Wolff, A. Barger, R. Berliner, L. Bette, P. Cannon, W. Cirksena, F. Reubi, J. Laragh, M. Levitt, M. Goldberg, M. Goldstein, W. Suki, K. Thurau, and J. Orloff: The physiology of diuretic agents. Ann. N. Y. Acad. Sci.139 237 (1966).
Siegenthaler, W.: Klinische Pathophysiologie. Stuttgart: Georg Thieme. (Im Druck.)
—— Klinische Syndrome mit Hyperaldosteronismus unter besonderer Berücksichtigung pathogenetischer Gesichtspunkte. Schweiz. med. Wschr.93 1803 (1963).
—— C. Werning, K. Baumann, M. Schönbeck, E. Gysling u. P. Weidmann: Das Renin-Angiotensin-Aldosteron-System mit besonderer Berücksichtigung seines Funktionszustandes unter dem Einfluß von Diuretika. In: Klinische Pharmakologie und Indikation der Saluretika, hrsg. von F. Krück. München: Urban & Schwarzenberg 1969.
Skeggs, L. T., J. R. Kahn, and N. P. Shumway: The preparation and function of the hypertensin converting enzyme. J. exp. Med.103 295 (1956).
—— K. E. Lentz, H. Hochstrasser, and J. R. Kahn: The purification and partial characterization of several forms of hog renin substrate. J. exp. Med.118 73 (1963).
-- -- J. R. Kahn, and H. Hochstrasser: Studies on the preparation and properties of renin. Circulat. Res., Suppl.II-91 (1967).
—— —— —— —— Kinetics of the reaction of renin with nine synthetic peptide substrates. J. exp. Med.218 13 (1968).
Sturm, A., Jr., u. H. W. Scheja: Untersuchungen über die Wirkung des Angiotensins II auf den Katecholaminstoffwechsel beim Menschen. Klin. Wschr.46 658 (1968).
Suki, W., F. Rector, and D. Seldin: The site of action of furosemide and other sulfonamide diuretics in the dogs. J. clin. Invest.44 1458 (1965).
Taquini, A. C., Jr., P. C. Blaquier, and D. F. Bohr: Neurogenic factors and angiotensin in etiology of hypertension. Amer. J. Physiol.201, 1173 (1961).
Thurau, K.: Renal hemodynamics. Amer. J. Med.36 698 (1964).
——, u. P. Deetjen: Die Diurese bei arteriellen Drucksteigerungen. Bedeutung der Haemodynamik des Nierenmarks für die Harnkonzentrierung. Pflügers Arch. ges. Physiol.274 567 (1962).
—— —— u. K. Kramer: Haemodynamik des Nierenmarks. Pflügers Arch. ges. Physiol.270 270 (1960).
——, u. K. Kramer: Weitere Untersuchungen zur myogenen Natur der Autoregulation des Nierenkreislaufes. Pflügers Arch. ges. Physiol.269 277 (1959).
——, u. J. Schnermann: Die Natriumkonzentration an den Macula-densa-Zellen als regulierender Faktor für das Glomerulumfiltrat. Klin. Wschr.43 410 (1965).
Tobian, L.: Physiology of the iuxtaglomerular cells. Ann. intern. Med.522 395 (1960).
—— Interrelationship of electrolytes, iuxtaglomerular cells and hypertension. Physiol. Rev.40 280 (1960).
Tobian, L.: Sodium renal arterial distention and the iuxtaglomerular apparatus. Canad. med. Ass. J.90 160 (1964).
—— Renin release and its role in renal function and the control of salt balance and arterial pressure. Fed. Proc.26 48 (1966).
—— J. Janecek, and A. Tomboulian: Correlation between granulation of iuxtaglomerular cells and extractable renin in rats with experimental hypertension. Proc. Soc. exp. Biol. (N. Y.)100 94 (1959).
—— —— —— The effect of a high sodium intake on development of permanent nephrosclerotic hypertension. J. Lab. clin. Med.53 842 (1959).
Tubash, G. D., and W. S. Peart: Purification of human renin. Biochim. biophys. Acta (Amst.)122 289 (1966).
Unveröffentlichte Befunde. (C. Werning.)
Valloton, M. B., L. B. Page, and E. Haber: Radioimmunoassay of angiotensin in human plasma. Nature (Lond.)215 714 (1967).
Vander, A. J.: Inhibition of distal tubular sodium reabsorption by angiotensin II. Amer. J. Physiol.205 133 (1963).
—— Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Amer. J. Physiol.209 659 (1965).
—— Control of renin release. Physiol. Rev.47 359 (1967).
——, and J. R. Luciano: Effects of mercurial diuresis and acute sodium depletion on renin release in dog. Amer. J. Physiol.212 651 (1967).
-- -- Neural and humoral control of renin release in salt depletion. Circulat. Res., Suppl.II-69 (1967).
——, and R. Miller: Control of renin secretion in the anesthetized dog. Amer. J. Physiol.207 537 (1964).
Wagermark, J., U. Ungerstedt, and A. Ljungqvist: Sympathetic innervation of the iuxtaglomerular cells of the kidney. Circulat. Res.22 149 (1968).
Warren, B., A. G. Johnson, and S. W. Hoobler: Characterization of the renin-antirenin system. J. exp. Med.123 1109 (1966).
Warzynski, R., Y. Demirjian, and S. Hoobler: A method for the determination of „renin“ in blood and some preliminary findings. Canad. med. Ass. J.90 225 (1964).
Weidmann, P., u. W. Siegenthaler: Das Renin-Angiotensin-Aldosteron-System bei hypertensiven Zuständen. Dtsch. med. Wschr.92 1953 (1967).
Werle, E., K. Baumeister, and A. Schmal: On the reninlike enzyme in the submaxillary gland of the white mouse. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.244 21 (1962).
Werning, C., K. Baumann, M. Schönbeck, E. Gysling, P. Weidmann u. W. Siegenthaler: Die Wirkung länger dauernder Hydrochlorothiazid-Gaben auf die Plasma-Renin-Aktivität und die Aldosteron-Exkretionsrate bei Normalpersonen. Klin. Wschr.47 318 (1969).
—— —— P. Weidmann, E. Gysling u. W. Siegenthaler: Die Plasmareninaktivität bei dekompensiertem und nicht dekompensiertem Diabetes insipidus. Zugleich ein Beitrag zur Regulation der Reninsekretion. Schweiz. med. Wschr.99 661 (1969).
——, M. Schönbeck, W. H. Ziegler, K. Baumann, E. Gysling, P. Weidmann u. W. Siegenthaler C: Die Adrenalin- und Noradrenalinausscheidung während Angiotensin II-Infusionen in die Arteria carotis beim narkotisierten Hund. Klin. Wschr.47, 640 (1969).
Wilson, I. M., and E. D. Freis: Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide. Circulation20 1028 (1959).
Wolff, H. P.: Der sekundäre Aldosteronismus Herz-Leber- und Nierenkranker. Verh. dtsch. Ges. inn. Med.68, 630 (1962).
Woodburne, R. Th.: Essential of human anatomy. 2nd ed. New York and Oxford. Univ. Press 1961.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Werning, C., Siegenthaler, W. Das Renin-Angiotensin-Aldosteron-System in pathophysiologischer Sicht. Klin Wochenschr 47, 1247–1255 (1969). https://doi.org/10.1007/BF01487550
Issue Date:
DOI: https://doi.org/10.1007/BF01487550